PreveCeutical advances drug delivery tech with Sol-Gel platform, eyes multi-asset spinouts

PreveCeutical Medical is evolving into a multi-asset business, spinning out its research programs into standalone entities. Their Sol-Gel platform offers a nasal drug delivery system designed for sustained release and direct nose-to-brain delivery, potentially treating…

Listen